RxSight, Inc.
RXST · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $30 | $40 | $28 | $17 |
| Short-Term Investments | $198 | $187 | $201 | $221 |
| Receivables | $24 | $28 | $31 | $30 |
| Inventory | $29 | $25 | $24 | $22 |
| Other Curr. Assets | $3 | $3 | $5 | $5 |
| Total Curr. Assets | $284 | $284 | $288 | $294 |
| Property Plant & Equip (Net) | $23 | $24 | $23 | $24 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $1 | $1 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1 | $1 | $1 | $1 |
| Total NC Assets | $25 | $25 | $25 | $25 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $309 | $309 | $313 | $319 |
| Liabilities | – | – | – | – |
| Payables | $3 | $3 | $7 | $5 |
| Short-Term Debt | $1 | $1 | $1 | $1 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $3 |
| Other Curr. Liab. | $18 | $16 | $15 | $17 |
| Total Curr. Liab. | $22 | $20 | $23 | $26 |
| LT Debt | $10 | $11 | $11 | $11 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $10 | $11 | $11 | $11 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $10 | $12 | $12 | $12 |
| Total Liabilities | $33 | $31 | $34 | $37 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$652 | -$642 | -$630 | -$622 |
| AOCI | $0 | -$0 | $0 | $0 |
| Other Equity | $928 | $920 | $910 | $903 |
| Total Equity | $276 | $278 | $279 | $281 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $309 | $309 | $313 | $319 |
| Net Debt | -$18 | -$29 | -$16 | -$4 |